4 Einträge gefunden

1. Treatment of refractory germ-cell tumours with single-agent cabazitaxel:a German Testicular Cancer Study Group case series

   1. Oing, Christoph
   2. Hentrich, Marcus
   3. Lorch, Anja
   4. Gläser, Dietrich
   5. Rumpold, Holger
   6. Ochsenreither, Sebastian
   7. Richter, Stephan

   2020 - Forschungsinformationssystem des UKE
2. Everolimus in patients with multiply relapsed or cisplatin refractory germ cell tumors: results of a phase II, single-arm, open-label multicenter trial (RADIT) of the German Testicular Cancer Study Group

   1. Fenner, Martin
   2. Oing, Christoph
   3. Dieing, Annette
   4. Gauler, Thomas
   5. Oechsle, Karin
   6. Lorch, Anja
   7. Hentrich, Marcus

   2019 - Forschungsinformationssystem des UKE
3. Efficacy and safety of gemcitabine, oxaliplatin, and paclitaxel in cisplatin-refractory germ cell cancer in routine care-Registry data from an outcomes research project of the German Testicular Cancer Study Group

   1. Seidel, Christoph
   2. Oechsle, Karin
   3. Lorch, Anja
   4. Dieing, Annette
   5. Hentrich, Marcus
   6. Hornig, Mareike
   7. Grünwald, Viktor

   2016 - Forschungsinformationssystem des UKE
4. First salvage treatment in patients with advanced germ cell cancer after cisplatin-based chemotherapy: analysis of a registry of the German Testicular Cancer Study Group (GTCSG)

   1. Berger, Lars Arne
   2. Bokemeyer, Carsten
   3. Lorch, Anja
   4. Hentrich, Marcus
   5. Kopp, Hans-Georg
   6. Gauler, Thomas Christoph
   7. Beyer, Jörg

   2014 - Forschungsinformationssystem des UKE